Dual activity of triterpenoids: apoptotic versus antidifferentiation effects

被引:61
作者
Cipak, Lubos
Grausova, Lubica
Miadokova, Eva
Novotny, Ladislav
Rauko, Peter
机构
[1] Slovak Acad Sci, Canc Res Inst, Bratislava 83391, Slovakia
[2] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia
[3] Comenius Univ, Fac Nat Sci, Dept Genet, Bratislava 84215, Slovakia
[4] Kuwait Univ, Fac Pharm, Safat 13110, Kuwait
关键词
apoptosis; differentiation; triterpenoid; doxorubicin; antioxidant;
D O I
10.1007/s00204-006-0072-6
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 [卫生毒理学];
摘要
Triterpenoids are natural, biologically active compounds extracted from many plants. They possess antiinflammatory, anticancer, and antioxidant properties. In the report presented, antiproliferative effects and leukemia cell growth and apoptosis modulating activities of ursolic acid (UA) and oleanolic acid (OA) were investigated. Both triterpenoids are inhibitors of leukemia cell growth and inductors of apoptosis. However, when applied in combination with anthracycline antitumor antibiotic doxorubicin (Dox), UA and OA diversely modulate therapeutic efficacy of Dox, due to different antioxidant activities. Compare to OA showing synergism/additive effect with Dox, UA (stronger antioxidant) acts antagonistically and reduces leukemia cell growth inhibiting and differentiation effects induced by Dox. In conclusion, these findings suggest that although triterpenoids UA and OA can induce apoptosis, their antioxidant activities can interfere with the therapeutic effect of antitumor antibiotic Dox which mechanism of action is attributed to the production of reactive oxygen species.
引用
收藏
页码:429 / 435
页数:7
相关论文
共 31 条
[1]
MUTAGENICITY AND CARCINOGENICITY OF TOPOISOMERASE-INTERACTIVE AGENTS [J].
ANDERSON, RD ;
BERGER, NA .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1994, 309 (01) :109-142
[2]
CARMICHAEL J, 1987, CANCER RES, V47, P936
[3]
Oxidative stress involvement in chemically induced differentiation of K562 cells [J].
Chénais, B ;
Andriollo, M ;
Guiraud, P ;
Belhoussine, R ;
Jeannesson, P .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (01) :18-27
[4]
Choi YH, 2000, INT J ONCOL, V17, P565
[5]
ANALYSIS OF COMBINED DRUG EFFECTS - A NEW LOOK AT A VERY OLD PROBLEM [J].
CHOU, TC ;
TALALAY, P .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1983, 4 (11) :450-454
[6]
Differential modulation of cisplatin and doxorubicin efficacies in leukemia cells by flavonoids [J].
Cipák, L ;
Novotny, L ;
Cipáková, I ;
Rauko, P .
NUTRITION RESEARCH, 2003, 23 (08) :1045-1057
[7]
Cipák L, 2003, LEUKEMIA RES, V27, P65, DOI 10.1016/S0145-2126(02)00063-2
[8]
COMPARISON OF ABILITY OF PROTEIN-KINASE-C INHIBITORS TO ARREST CELL-GROWTH AND TO ALTER CELLULAR PROTEIN-KINASE-C LOCALIZATION [J].
COURAGE, C ;
BUDWORTH, J ;
GESCHER, A .
BRITISH JOURNAL OF CANCER, 1995, 71 (04) :697-704
[9]
Debes A, 2003, ANTICANCER RES, V23, P3359
[10]
CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas [J].
Dorothy, PA ;
Pan, D ;
Qin, J ;
Farber, C ;
O'Brien, J ;
Filippa, D ;
Portlock, CS .
LEUKEMIA & LYMPHOMA, 2003, 44 (06) :967-971